APA

Redondo A., Ramos Vázquez M., Manso L., Gil Gil M. J., Garau Llinas I., García-Garre E., Rodríguez C. A., Chacón J. I. & López-Vivanco G. (2018). Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. : OncoTargets and therapy.

Chicago

Redondo Andrés, Ramos Vázquez Manuel, Manso Luis, Gil Gil Miguel J, Garau Llinas Isabel, García-Garre Elisa, Rodríguez César A, Chacón José Ignacio and López-Vivanco Guillermo. 2018. Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. : OncoTargets and therapy.

Harvard

Redondo A., Ramos Vázquez M., Manso L., Gil Gil M. J., Garau Llinas I., García-Garre E., Rodríguez C. A., Chacón J. I. and López-Vivanco G. (2018). Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. : OncoTargets and therapy.

MLA

Redondo Andrés, Ramos Vázquez Manuel, Manso Luis, Gil Gil Miguel J, Garau Llinas Isabel, García-Garre Elisa, Rodríguez César A, Chacón José Ignacio and López-Vivanco Guillermo. Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. : OncoTargets and therapy. 2018.